Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p1
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 1/191)
Character Range: 9451893–9467000

1  Circumstances, purposes and conditions
  The following table sets out:
 (a) circumstances for circumstances codes, for the purposes of section 13 and 23; and
 (b) purposes for purposes codes, for the purposes of sections 15 and 16; and
 (c) for the purposes of section 19, information relating to how authorisation is obtained when the circumstances or conditions for writing a prescription include an authorisation requirement.

Circumstances Code  Purposes Code  Conditions Code  Listed Drug                                                                                                                                                                Circumstances and Purposes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Authority Requirements (part of Circumstances; or Conditions)

C4076               P4076          CN4076           Atenolol                                                                                                                                                                   For a patient who is unable to take a solid dose form of atenolol.

C4077               P4077          CN4077           Granisetron                                                                                                                                                                Nausea and vomiting
                                                                                                                                                                                                                               The condition must be associated with cytotoxic chemotherapy being used to treat malignancy which occurs within 48 hours of chemotherapy administration.
C4084               P4084          CN4084           Mycophenolic acid                                                                                                                                                          Prophylaxis of renal allograft rejection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures - Streamlined Authority Code 4084
                                                                                                                                                                                                                               Management
                                                                                                                                                                                                                               The treatment must be under the supervision and direction of a transplant unit.
C4092               P4092          CN4092           Granisetron                                                                                                                                                                Nausea and vomiting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 4092
                                                                                                                                                                                                                               The condition must be associated with radiotherapy being used to treat malignancy.
C4095               P4095          CN4095           Mycophenolic acid                                                                                                                                                          WHO Class III, IV or V lupus nephritis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 4095
                                                                                                                                                                                                                               Management
                                                                                                                                                                                                                               The condition must be proven by biopsy; AND
                                                                                                                                                                                                                               Must be treated by a nephrologist or in consultation with a nephrologist.
                                                                                                                                                                                                                               The name of the consulting nephrologist must be included in the patient medical records.
C4098               P4098          CN4098           Apixaban                                                                                                                                                                   Deep vein thrombosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4098
                                                                                                                                                                                                                               Initial treatment
                                                    Rivaroxaban                                                                                                                                                                Patient must have confirmed acute symptomatic deep vein thrombosis; AND
                                                                                                                                                                                                                               Patient must not have symptomatic pulmonary embolism.
C4099               P4099          CN4099           Apixaban                                                                                                                                                                   Deep vein thrombosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4099
                                                                                                                                                                                                                               Continuing treatment
                                                    Rivaroxaban                                                                                                                                                                Patient must have confirmed acute symptomatic deep vein thrombosis; AND
                                                                                                                                                                                                                               Patient must not have symptomatic pulmonary embolism.
C4105               P4105          CN4105           Hyaluronic acid                                                                                                                                                            Severe dry eye syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with Authority Required procedures - Streamlined Authority Code 4105
                                                                                                                                                                                                                               Patient must be sensitive to preservatives in multi-dose eye drops.
C4118               P4118          CN4118           Granisetron                                                                                                                                                                Nausea and vomiting
                                                                                                                                                                                                                               The condition must be associated with cytotoxic chemotherapy being used to treat malignancy which occurs within 48 hours of chemotherapy administration.
                                                    Ondansetron

C4124               P4124          CN4124           Naproxen                                                                                                                                                                   Bone pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 4124
                                                                                                                                                                                                                               The condition must be due to malignant disease; AND
                                                                                                                                                                                                                               Patient must be unable to take a solid dose form of a non-steroidal anti-inflammatory agent.
C4132               P4132          CN4132           Apixaban                                                                                                                                                                   Prevention of recurrent venous thromboembolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures - Streamlined Authority Code 4132
                                                                                                                                                                                                                               Continuing treatment
                                                    Rivaroxaban                                                                                                                                                                Patient must have a history of